Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CPT2 | P23786 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | ACLY | P53396 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| .Beta.-Hydroxyisovaleric Acid SCHEMBL95499 | 0.89 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL7411873 | 0.88 | HMGCR (0.48) | HMGCRCHRM1TBXA2RADRA1ACYP2C19 | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL5101729 | 0.86 | HMGCR (0.57) | HMGCRCHRM1TBXA2RADRA1ACYP2C19 | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL10277346 | 0.86 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL30764083 | 0.86 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL2340215 | 0.86 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL29991820 | 0.86 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL723161 | 0.86 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL925875 | 0.86 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL5159910 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020082083-A1 | METHODS AND COMPOSITIONS FOR LOCALIZED INTRADUCTAL DRUG DELIVERY TO THE BREAST AND REGIONAL LYMPH NODES | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-04-23 | — | — | WO | disclosed |
| US-20200121605-A1 | METHODS AND COMPOSITIONS FOR LOCALIZED INTRADUCTAL DRUG DELIVERY TO THE BREAST AND REGIONAL LYMPH NODES | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-04-23 | — | — | US | disclosed |
| US-6743784-B2 | TRIARYLETHANES FOR TREATING SYMPTOMS, DISEASES AND CONDITIONS IN EXTRA-REPRODUCTIVE TRACT TISSUES, SUCH AS OSTEOPENIA, THAT ARE RESPONSIVE TO TREATMENT WITH ESTROGEN | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2004-06-01 | — | — | US | disclosed |
| US-20020045664-A1 | Estrogen mimetics lacking reproductive tract effects | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC | 2002-04-18 | — | — | US | disclosed |
| US-6323190-B1 | REPRODUCTIVE TRACT TISSUES AND CARDIOVASCULAR DISORDERS | THE UNIVERISTY OF GEORGIA RESEARCH FOUNDATION, INC. | 2001-11-27 | — | — | US | disclosed |
| US-5869319-A | FACULTATIVE ANAEROBE WHICH PRODUCES 7-BETA-HYDROXY BILE ACIDS FROM SUBSTRATES HAVING 7-ALPHA-HYDROXY OR 7-KETO GROUPS FOR SAFE, SIMPLE, EFFICIENT COMMERCIAL PRODUCTION | TOKYO TANABE COMPANY LIMITED (JP) | 1999-02-09 | — | — | US | disclosed |
| EP-0872546-A1 | NOVEL BILE ACID-CONVERTING MICROORGANISM | TOKYO TANABE COMPANY LIMITED (JP) | 1998-10-21 | — | — | EP | disclosed |
| US-4950428-A | TWENTY KETO PREGNANES; PHARMACOLOGICAL PROPERTIES; STARTING MATERIALS FOR RECONSTRUCTION OF DEOXYCORTISONE CHAIN | ROUSSEL UCLAF (FR) | 1990-08-21 | — | — | US | disclosed |
| US-4847014-A | CHEMICAL INTERMEDIATES, DEHYDROHALOGENATION | ROUSSEL UCLAF (FR) | 1989-07-11 | — | — | US | disclosed |
| US-4801697-A | BRONCHODILATOR, MUSCLE RELAXANT, HORMONE EXCRETION STIMULANT | TOYO JOZO KABUSHIKI KAISHA (JP) | 1989-01-31 | — | — | US | disclosed |
| US-4711879-A | IMMUNO-MODULATING ACTIVITY | CIBA-GEIGY CORPORATION (US) | 1987-12-08 | — | — | US | disclosed |
| US-4693998-A | STIMULATE THE IMMUNE SYSTEM | AGENCE NATIONALE DE VALORISATION DE LA RECHERSCHE (FR) | 1987-09-15 | — | — | US | disclosed |
| US-4640911-A | IMMUNOSTIMULANTS, VIRICIDES SUCH AS HERPES SIMPLEX | CIBA-GEIGY CORPORATION (US) | 1987-02-03 | — | — | US | disclosed |
| US-4595675-A | Hypotensive agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-06-17 | — | — | US | disclosed |
| US-4548923-A | IMMUNOSTIMULANTS, BACTERICIDES, VIRICIDES | CIBA GEIGY CORPORATION (US) | 1985-10-22 | — | — | US | disclosed |
| US-4423038-A | Phosphoryl compounds, pharmaceutical preparations containing such compounds, and their use | CIBA-GEIGY CORPORATION (US) | 1983-12-27 | — | — | US | disclosed |
| US-4406889-A | IMMUNOLOGY, PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1983-09-27 | — | — | US | disclosed |
| EP-0003069-B1 | PSEUDOMONIC ACID C, PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL OR VETERINARY COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1981-05-20 | — | — | EP | disclosed |
| US-4226880-A | PSEUDOMONIC ACID C AND DERIVATIVES | BEECHAM GROUP LIMITED (GB) | 1980-10-07 | — | — | US | disclosed |
| US-4205002-A | PSEUDOMONIC ACID C AND DERIVATIVES | BEECHAM GROUP LIMITED (GB) | 1980-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200121605-A1 | METHODS AND COMPOSITIONS FOR LOCALIZED INTRADUCTAL DRUG DELIVERY TO THE BREAST AND REGIONAL LYMPH NODES | LDHB, LDHA, LIPA | HMGCR 1165/4885CHRM1 4458/4885TBXA2R 4399/4885 |
| US-20020045664-A1 | Estrogen mimetics lacking reproductive tract effects | ESR2, ESRRA, GPER1 | HMGCR 571/4885CHRM1 155/4885TBXA2R 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.